Blog - Page 979 of 5701 - QualityStocks

MondayMay 16, 2022 2:52 pm

QualityStocksNewsBreaks – Tingo Inc. (TMNA) Announces Q1 2022 Financial Results

Tingo (OTC: TMNA), the leading agri-fintech company operating in Africa, has filed its quarterly report on Form 10-Q, wherein the company reported its financial results for the three months ended March 31, 2022. Among the highlights, Tingo reported $257.1 million and $65.5 million in consolidated revenue and operating income, respectively, during the first quarter of 2022. In addition, the company announced a 19.2% quarter-on-quarter growth in gross profit to $153.2 million, up from $128.5 million for Q4 2021. “We are very pleased to report strong operating performance for the first quarter of 2022 and the continued growth of our agri-fintech…

MondayMay 16, 2022 2:35 pm

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Issues Update on Default Status

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, announced that it is providing a default status report; the report is being released in accordance with the alternative information guidelines set out in National Policy 12-203 — Management Cease Trade Orders (“NP 12-203”). According to the announcement, Delic is experiencing delays to its audit, which means that the required annual financial statements and management's discussion and analysis for FY 2021 have been delayed as well. The company had requested that a management cease trade order (“MCTO”) be imposed as a result…

MondayMay 16, 2022 2:18 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Q1 2022 Financial, Corporate Update

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has released its first quarter 2022 financial report along with key updates on company strategies. The report pointed to recent approvals of a potentially pivotal Berubicin study in Europe that is expected to significantly drive patient enrollment and opportunities for Berubicin to be used in additional oncology indications with significant unmet needs and also noted that CNSP was granted fast track designation for Berubicin from the FDA, which provides more frequent interactions with the…

MondayMay 16, 2022 1:58 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN), LGG Report on Vehicle Pack Development of Battery Cell Tech

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released an update on its partnership with Linghang Guochuang Group (“LGG”). According to the update, the two companies are working together to take solid-state polymer battery cell technology into vehicle pack level development, with solid-state polymer batteries being anticipated to be available for the second generation of the Mullen FIVE EV Crossover. The two companies announced their partnership in 2019 and then progress was sidelined in 2020 because of COVID-19 outbreak. Recently, Mullen and LGG have picked up again, starting integration of the solid-state polymer cell technology into the…

MondayMay 16, 2022 1:49 pm

QualityStocksNewsBreaks – Lottery.com (NASDAQ: LTRY) Releases Q1 Financial, Operational Results

Lottery.com (NASDAQ: LTRY), a leading technology company that is transforming how, where and when the lottery is played, is reporting its first quarter 2022 financial results for the period ended March 31, 2022. Highlights of the report include Q1 revenue of $21.2 million, an increase of $15.7 million from the same period the previous year, as well as gross profit totaling $18 million, up $15.5 million from first quarter 2021. The report stated that the company experience Q1 2022 net loss of $15.8 million and adjusted EBITDA of $7.7 million. In addition, the report noted an update on key initiatives…

MondayMay 16, 2022 1:31 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Strategic Appointment of Cannabis Regulatory Veteran

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced its appointment of regulatory veteran Holly Bell as vice president of regulatory affairs. According to the update, Bell will play a crucial role in Flora’s domestic and global expansion strategy and lead government relations in key international markets. “Holly’s unique knowledge and understanding of the United States’ regulatory framework will position us to make thoughtful, educated and bold decisions regarding strategic distribution, cultivation and sales plans,” said Luis Merchan, president and CEO of Flora Growth. “We look forward to bringing Holly’s expertise…

MondayMay 16, 2022 11:15 am

SPYR Inc. (SPYR) Probing Considerations Aimed at Fueling Expansion Amid Expected Growth in the Internet of Things

The ‘Internet of Things’ market is expected to reach a value of between $5.5 trillion and $12.6 trillion by 2030, from $745 billion in 2019, driven by contributions from both businesses and consumers SPYR Inc., through its subsidiary Applied Magix Inc., is considering aligning its interests to tap into this anticipated rapid growth The company is considering developing software for non-branded smart products, adding smart LED lighting products to its portfolio of HomeKit-enabled smart products, and acquiring new product lines or intellectual property Research released late last year by multinational consulting firm McKinsey posits that the Internet of Things (“IoT”)…

MondayMay 16, 2022 10:30 am

Aditxt Inc. (NASDAQ: ADTX) Is ‘One to Watch’

Aditxt is commercializing new innovations with focus on mapping and reprogramming the immune system Aditxt is actively adding distribution channel partners for AditxtScore(TM) throughout the U.S. and globally The company aims to expand reimbursement coverage for AditxtScore(TM) for COVID-19 from private insurance and public payers while developing and commercializing tests for other indications Aditxt intends to advance its ADi(TM) therapeutics pipeline into clinical trials in the coming months, with initial studies targeting psoriasis, type 1 diabetes, and skin allograft transplantation The company is led by a team of experts coming from a variety of different scientific fields and business backgrounds…

MondayMay 16, 2022 9:00 am

Knightscope, Inc.’s (NASDAQ: KSCP) Autonomous Security Robots Facilitating Situational Crime Prevention

The various opportunity-reducing methods of situational crime prevention look to increase the perceived risks of committing a crime, enhance the effort required to commit crimes, reduce rewards, and eliminate excuses for crime Knightscope’s autonomous security robots (“ASRs”), which are equipped with capabilities such as video recording and streaming capabilities, thermal anomaly detection, facial recognition, and more, help to increase the perceived risks associated with criminal activities, resulting in deterrence Following the deployment of ASRs, Knightscope’s clients have reported considerable reductions in the number of crimes reported Knightscope recently added another client – a New York shopping center – and visited…

Site Search

Company Search